11th University of Virginia (UVA) Annual Conference of Liver Disease and Gastroenterology
In-Person Event
Jun 10 - 11, 2016
Charlottesville, Virginia, USASpeakers
OVERVIEW
11th UVA Annual Conference of Liver Disease and Gastroenterology is organized by University of Virginia School of Medicine and would be held during Jun 10 - 11, 2016 at University Of Virginia - Darden Business School, Charlottesville, Virginia, United States Of America.
The targeted audience for this medical event is basically for gastroenterology physicians, general, internal medicine and family medicine physicians, physician’s assistants and nurse practitioners and those who has interest to learn about and discuss the advances in the diagnosis and treatment of patients with liver disease and luminal GI diseases.
This conference has been approved with 8.5 AMA PRA credits.
Educational objectives :
- Understanding the role of endoscopic mucosal resection in the colon
- Understand the role of surgical management in the treatment of pancreatic cancer
- Determine the role of H. pylori in the development of gastrointestinal disease
- Recognize the use of new therapies for treatment of Nonalcoholic Steatohepatitis (NASH)
- Distinguish the imaging characteristics, natural history and medical management of liverlesions
- Recognize imaging and presentation of hepatocellular carcinoma
- Identify the contraindications and optimal characteristics of candidates for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- Understand the TIPS complications associated with hepatic encephalopathy
- Recognize new and conventional technologies for the diagnosis and treatment of small bowel GI bleeding
- Understand the risks and benefits of EMR In the management of gastrointestinalpolyps
- Recognize emerging surgical therapies for treatment of rectal lesions and cancers
- Discriminate between various colorectal cancer screening modalities
- Distinguish new treatment options for inflammatory bowel disease
- Recognize the pathophysiology of non-celiac gluten sensitivity
- Identify diagnostics and therapies for primary sclerosing cholangitis and primary biliary cirrhos.
The targeted audience for this medical event is basically for gastroenterology physicians, general, internal medicine and family medicine physicians, physician’s assistants and nurse practitioners and those who has interest to learn about and discuss the advances in the diagnosis and treatment of patients with liver disease and luminal GI diseases.
This conference has been approved with 8.5 AMA PRA credits.
Educational objectives :
- Understanding the role of endoscopic mucosal resection in the colon
- Understand the role of surgical management in the treatment of pancreatic cancer
- Determine the role of H. pylori in the development of gastrointestinal disease
- Recognize the use of new therapies for treatment of Nonalcoholic Steatohepatitis (NASH)
- Distinguish the imaging characteristics, natural history and medical management of liverlesions
- Recognize imaging and presentation of hepatocellular carcinoma
- Identify the contraindications and optimal characteristics of candidates for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- Understand the TIPS complications associated with hepatic encephalopathy
- Recognize new and conventional technologies for the diagnosis and treatment of small bowel GI bleeding
- Understand the risks and benefits of EMR In the management of gastrointestinalpolyps
- Recognize emerging surgical therapies for treatment of rectal lesions and cancers
- Discriminate between various colorectal cancer screening modalities
- Distinguish new treatment options for inflammatory bowel disease
- Recognize the pathophysiology of non-celiac gluten sensitivity
- Identify diagnostics and therapies for primary sclerosing cholangitis and primary biliary cirrhos.
KEY DATES
10 Jun, 2016
Event Start Date
11 Jun, 2016
Event End Date
SPECIALITIES
GastroenterologyHepatologySUGGESTED HOTELS
CONFERENCE VENUE
University Of Virginia - Darden Business SchoolRELATED CONFERENCES & LIVE WEBINARS
Quick Links